MedTrace Logo

Older Adults' Attitudes Towards Stopping Aspirin

NCT07305376 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2819

Last updated 2026-04-29

No results posted yet for this study

Summary

This online, survey-based experiment will include 2,400 adults who are 65 years and older (n=1,200 each from the United States and Australia). Each participant will be asked to share their opinions on a hypothetical patient scenario developed by our multidisciplinary team. This work is expected to significantly contribute to the understanding of how older adults make decisions about deprescribing medications. The long-term goal is to enhance communication between older adults and clinicians so that medication regimens are optimized and align with care preferences. These results will directly inform future research on the impact of communication choices in clinical practice.

Conditions

  • Medication Overuse

Interventions

OTHER

Additional harm information

Participants received additional information about the harm of continuing aspirin.

OTHER

Less information

Participants will receive less information about the risk of harms of continuing aspirin.

Sponsors & Collaborators

Principal Investigators

  • Sarah Vordenberg, PharmD, MPH · University of Michigan

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-11-10
Primary Completion
2025-11-30
Completion
2025-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07305376 on ClinicalTrials.gov